Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Food Effect on PK of DWJ1458 in Healthy Adults
NCT04393597Phase 1Withdrawn
- Sponsor
- Daewoong Pharmaceutical
- Start
- May 2020
- Primary completion
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of DWJ1458 in Alzheimer's disease (AD) (2 arms), sponsored by Daewoong Pharmaceutical. Primary endpoints: Area Under the Concentration-time Curve from time 0 to time t and Maximum Plasma Concentration. Planned start May 2020; status: withdrawn.
02
Drugs
DWJ1458
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT04393597.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04393597.